在韩国患有血液性恶性瘤的患者中,甲铁酸的群体药动力学模型
Yun Seob Jung1,2, Mijeong Son1, Sang-Guk Lee3
1Department of Pharmacology, Yonsei University College of Medicine, Seoul, South Korea.
British journal of clinical pharmacology
|November 20, 2023
概括
这项研究在韩国患有血液性恶性瘤的患者中开发了一种基因基因基因的基因基因基因模型. 该模型允许精确的,个性化的剂量,以改善治疗结果.
科学领域:
- 药理动力学和药理动力学
- 在瘤学瘤学.
- 临床药理学 临床药理学
背景情况:
- 甲基 (MTX) 是血液恶性瘤的关键化疗剂.
- 在MTX药理动力学 (PK) 中的个体变化需要特定于人群的剂量策略.
- 对韩国患有血液性恶性瘤的患者缺乏已确立的PK模型.
研究的目的:
- 在韩国患有血液性恶性瘤的患者中开发一种基因基因基因基因的基因基因基因基因模型.
- 在这个人群中确定影响甲状腺素PK的关键因素.
- 建议针对韩国患者量身定制的优化甲状腺素剂量方案.
主要方法:
- 从188名患有急性白血病或非霍奇金淋巴瘤的韩国患者回顾性数据收集.
- 使用NONMEM软件进行人口PK建模.
- 同变量分析以确定影响MTX PK的因素,包括年龄和血清肌素.
主要成果:
- 开发了一种两部分的PK模型,其中包含了全米体重.
- 清除 (CL) 受年龄和血清肌水平的显著影响.
- 开发的模型和模拟的最佳剂量实现了目标PK措施,类似于西方和中国人口.
结论:
- 人口PK模型为在韩国患者中精确剂量甲状腺素的准确剂量提供了基础.
- 年龄和功能是优化甲铁酸剂量至关重要的共同变量.
- 个性化剂量策略可以提高治疗效果,并最大限度地减少这种患者群体的毒性.
相关概念视频
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
73
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
73
Pharmacokinetic Models: Overview
717
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
717
Pharmacokinetic Models: Comparison and Selection Criterion
78
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
78
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
41
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
41
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
526
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
526
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
138
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
138


